Ещё нет его.

я так и думал что вброс, тут может быть либо фиговый отчет, либо так себе

@dav0910 есть

Evolent Health (NYSE: EVH) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.10) by 70 percent. This is a 88.46 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $238.60 million which missed the analyst consensus estimate of $241.03 million by 1.01 percent. This is a 24.19 percent increase over sales of $192.12 million the same period last year.